207 related articles for article (PubMed ID: 9892091)
1. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
[TBL] [Abstract][Full Text] [Related]
2. Molecular characteristics of meningiomas in a cohort of Indian patients: loss of heterozygosity analysis of chromosomes 22, 17, 14 and 10.
Asirvatham JR; Pai R; Chacko G; Nehru AG; John J; Chacko AG; Muliyil J
Neurol India; 2013; 61(2):138-43. PubMed ID: 23644312
[TBL] [Abstract][Full Text] [Related]
3. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
4. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
6. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.
Lindblom A; Ruttledge M; Collins VP; Nordenskjöld M; Dumanski JP
Int J Cancer; 1994 Feb; 56(3):354-7. PubMed ID: 8314321
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas.
Lekanne Deprez RH; Riegman PH; van Drunen E; Warringa UL; Groen NA; Stefanko SZ; Koper JW; Avezaat CJ; Mulder PG; Zwarthoff EC
J Neuropathol Exp Neurol; 1995 Mar; 54(2):224-35. PubMed ID: 7876890
[TBL] [Abstract][Full Text] [Related]
12. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
13. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
15. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.
Baser ME; Poussaint TY
J Med Genet; 2006 Mar; 43(3):285-7. PubMed ID: 15980114
[TBL] [Abstract][Full Text] [Related]
16. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss at 1p is associated with tumor progression of meningiomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
[TBL] [Abstract][Full Text] [Related]
18. Search for putative suppressor genes in meningioma: significance of chromosome 22.
Schneider G; Lutz S; Henn W; Zang KD; Blin N
Hum Genet; 1992 Mar; 88(5):579-82. PubMed ID: 1551661
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
20. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
